To include your compound in the COVID-19 Resource Center, submit it here.

Revlimid lenalidomide: Additional Phase III data

Additional data from 370 evaluable patients in a Phase III trial showed that following induction treatment with Revlimid plus low-dose dexamethasone resulted in at least a partial

Read the full 271 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE